Burning, urgency, and pelvic discomfort in midlife can closely resemble a urinary tract infection, even when routine testing does not identify an infection. The lower urinary tract—including the urethra, bladder neck, and trigone—is hormone responsive and can change during the menopausal transition alongside vulvar and vaginal tissue.[1,3,4]
Because infection and genitourinary syndrome of menopause can produce overlapping symptoms, they cannot always be reliably distinguished by symptoms alone. New, persistent, recurrent, or worsening urinary symptoms should be clinically evaluated.
Read this part first
If you have urinary symptoms, get them evaluated. Do not assume they are hormonal.
Seek care promptly for any of the following:
● fever, chills, or back or flank pain
● blood in the urine
● pain with urination that is new or worsening
● symptoms that persist, recur, or escalate
Untreated urinary tract infections can ascend to the kidneys. Fever, chills, flank or back pain, vomiting, visible blood in the urine, systemic illness, or rapidly worsening symptoms warrant prompt evaluation.
Urinalysis and, when indicated, urine culture help assess whether infection is present. Results should be interpreted alongside symptoms, examination findings, specimen quality, recent antibiotic use, and the broader clinical context.
What follows explains why these symptoms can occur without infection. It is not a way to avoid testing. It is context for the situation many women find themselves in: repeated cultures that come back negative, and symptoms that are entirely real.
Why the confusion happens
Most women are taught to think of the urinary tract and the genital tract as separate systems. Developmentally they are not, and — importantly — they share hormone responsiveness.
The urethra, the bladder trigone, and surrounding supportive tissue all carry receptors for the same hormones that act on vulvar and vaginal tissue.[1,2] When the hormonal environment changes in midlife, these tissues change too. Not as a side effect. As part of the same process.
This is why the clinical term is genitourinary syndrome of menopause rather than the older, narrower "vulvovaginal atrophy." The 2014 consensus definition explicitly names the urethra and bladder among affected tissues, and lists urgency, dysuria, and recurrent urinary tract infections among the syndrome's urinary symptoms.[1] The urinary component was recognized as part of the same biology.
What changes, and why it produces these particular symptoms
Thinning of the urethral lining. The urethra is lined with hormone-responsive tissue. As it thins, it becomes more sensitive to the passage of urine — producing burning without any organism present.[1,3]
Reduced tissue cushioning. Supportive tissue around the urethra contributes to its normal closure and comfort. As this changes, sensation changes with it.
Altered sensory signaling. The urethra and surrounding lower urinary tract are richly innervated, and changes in the mucosa, tissue environment, or afferent signaling may contribute to urgency or discomfort. The precise sensory mechanisms in the female human urethra remain incompletely understood.[7]
A shifted vaginal microbial environment. As glycogen availability falls, Lactobacillus populations decline and vaginal pH rises. This changes which organisms are present near the urethral opening.[2]
That last point deserves emphasis, because it cuts against the reassurance the rest of this article might seem to offer: midlife makes genuine infections more likely at the same time as it produces infection-like symptoms without infection. Both are true simultaneously.
Randomized trials have found that vaginal estrogen can reduce recurrent urinary tract infections in postmenopausal women, and current clinical guidelines recommend local low-dose vaginal estrogen for appropriately selected patients with GSM and recurrent UTI.[2,5,6]
Proposed mechanisms include changes in the vaginal epithelium, pH, and microbial environment, although clinical response varies and treatment decisions should be individualized.
The pattern women describe
Symptoms appear. A UTI seems obvious. A culture is ordered — negative. Antibiotics are sometimes given anyway. Symptoms improve briefly, or don't, and return. The cycle repeats, sometimes for years, often with the growing suspicion that no one believes the symptoms are real.
They are real. A negative routine culture does not mean that nothing is happening—but it also does not, by itself, prove that the cause is hormonal.
Routine culture can fail to detect low-count or difficult-to-culture organisms, particularly when testing thresholds, specimen collection, transport, or recent antibiotic exposure affect the result.[8] Conversely, noninfectious conditions—including genitourinary syndrome of menopause and other bladder, urethral, vulvar, or pelvic conditions—can produce similar symptoms.[3,6]
Persistent or recurrent symptoms therefore deserve further evaluation rather than repeated assumptions in either direction.
This distinction is worth carrying into a clinical appointment, because it changes the question from "do I have an infection?" to "if this isn't infection, what tissue change would explain it?" — and that is a question a clinician can work with.
What to bring to that appointment
● when symptoms occur, and whether anything reliably triggers them
● whether cultures have been done, and what they showed
● whether you have vulvar or vaginal symptoms alongside the urinary ones — dryness, irritation, discomfort with intimacy
● what has been tried and what happened
That third point is particularly useful. Urinary symptoms occurring alongside vulvar or vaginal dryness, irritation, pain, or discomfort may increase clinical suspicion for genitourinary syndrome of menopause because GSM can affect the vulva, vagina, urethra, and bladder as parts of the same hormone-responsive system.[1,3,6]
The pattern does not prove that hormones are the only cause, and infection or another urinary condition may coexist. It does, however, give the clinician a more complete picture to evaluate.
Where vulvar care fits, and where it doesn't
Caring for external vulvar tissue can make the whole area feel more comfortable, and for some women that meaningfully changes daily experience.
But the boundary needs to be explicit: a vulvar moisturizer does not treat infection, does not prevent infection, and does not replace urine testing or medical care. Restore is designed to moisturize and condition dry or sensitive external vulvar tissue.
If an infection is present, it needs treatment. If it isn't, that is worth establishing properly — because knowing what you are dealing with is what makes anything else possible.
For further education on midlife urinary and vulvovaginal health, VULVAi, led by our medical advisor Dr. Maria Uloko, is a good resource.
Frequently Asked Questions
Can menopause cause symptoms that feel like a UTI?
Yes. Genitourinary syndrome of menopause can include urinary urgency, frequency, burning with urination, discomfort, and recurrent urinary tract infections. It can affect the urethra and bladder as well as the vulva and vagina.[1,3,6]
These symptoms are not automatically caused by GSM, however. Infection and other urinary or pelvic conditions can produce similar symptoms, so new or worsening symptoms should be evaluated.
Does a negative urine culture mean that I do not have a UTI?
Not necessarily.
A negative routine culture makes a typical culture-confirmed infection less apparent, but it does not exclude every possible infection. Bacterial quantity, culture thresholds, specimen collection, recent antibiotics, transport conditions, and organisms that do not grow readily under standard conditions can influence the result.[8]
A negative culture also does not prove that symptoms are hormonal. Persistent or recurrent symptoms require interpretation in the context of urinalysis, symptoms, examination findings, previous results, and other possible causes.
How can midlife tissue changes cause urinary burning?
The urethra and parts of the lower urinary tract contain sex-hormone receptors and can undergo epithelial, connective-tissue, vascular, and sensory changes as the hormonal environment changes.[1,3,4,7]
More sensitive tissue near the urethral opening can produce burning or irritation when exposed to urine, friction, cleansers, or other irritants—even when routine testing does not identify an infection.
Why can GSM and urinary tract infections occur at the same time?
The menopausal transition can change the vulvovaginal epithelium, vaginal pH, and microbial environment. These changes may contribute both to noninfectious urinary discomfort and to increased susceptibility to genuine urinary tract infections.[1–3]
This is why symptoms should not automatically be classified as either “infection” or “hormonal.” Both processes can occur, and one does not exclude the other.
Can vaginal estrogen reduce recurrent UTIs?
For appropriately selected peri- and postmenopausal patients with recurrent urinary tract infections, local low-dose vaginal estrogen has been shown to reduce recurrence and is recommended in current clinical guidelines.[2,5,6]
Vaginal estrogen is a medical treatment and is not the same as an externally applied vulvar moisturizer. Suitability should be discussed with a qualified clinician, particularly when there is a history of hormone-sensitive cancer or another relevant medical condition.
Can a vulvar moisturizer treat a UTI?
No. A vulvar moisturizer cannot diagnose, treat, cure, or prevent a urinary tract infection.
An external vulvar moisturizer may help dry or sensitive external tissue feel more comfortable. It does not replace urinalysis, urine culture, medical evaluation, antibiotics when indicated, or treatment directed at another urinary condition.
When should urinary symptoms be evaluated urgently?
Seek prompt medical care for urinary symptoms accompanied by:
-
fever or chills;
-
back or flank pain;
-
vomiting or inability to keep fluids down;
-
visible blood in the urine;
-
difficulty passing urine;
-
significant weakness or systemic illness;
-
rapidly worsening pain or symptoms.
New, persistent, or repeatedly recurring urinary symptoms should also be evaluated, even when earlier cultures were negative.
Educational note: This content is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any medical condition. Urinary symptoms require evaluation by a qualified healthcare provider.
Last Reviewed: July 2026
By Laura Kelly, DAOM, L.Ac., Dipl. O.M. — A California-licensed primary care provider and nationally board-certified clinician with a clinical focus on women’s health and healthy aging. Research Scholar, Ronin Institute. ORCID: 0000-0001-6586-7308. More about Dr. Kelly
References
-
Portman DJ, Gass MLS; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American Menopause Society. Menopause. 2014;21(10):1063–1068. doi: 10.1097/GME.0000000000000329. PMID: 25160739.
-
Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. New England Journal of Medicine. 1993;329(11):753–756. doi: 10.1056/NEJM199309093291102. PMID: 8350884.
-
The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976–992. doi: 10.1097/GME.0000000000001609. PMID: 32852449.
-
Blakeman PJ, Hilton P, Bulmer JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU International. 2000;86(1):32–38. doi: 10.1046/j.1464-410x.2000.00724.x. PMID: 10886079.
-
Ferrante KL, Wasenda EJ, Jung CE, et al. Vaginal estrogen for the prevention of recurrent urinary tract infection in postmenopausal women: a randomized clinical trial. Female Pelvic Medicine & Reconstructive Surgery. 2021;27(2):112–117. doi: 10.1097/SPV.0000000000000749. PMID: 31232721.
-
Kaufman MR, Ackerman AL, Amin KA, et al. The AUA/SUFU/AUGS guideline on genitourinary syndrome of menopause. Journal of Urology. 2025;214(3):242–250. doi: 10.1097/JU.0000000000004589. PMID: 40298120.
-
Mueller M, Drumm BT, Hannan JL, Ruetten H. Advancing our understanding of the urothelium and lamina propria, hormone receptors, vascular supply, and sensory aspects of the female human urethra. Neurourology and Urodynamics. 2025;44(4):935–943. doi: 10.1002/nau.70003. PMID: 40103421.
-
Heytens S, De Sutter A, Coorevits L, et al. Women with symptoms of a urinary tract infection but a negative urine culture: PCR-based quantification of Escherichia coli suggests infection in most cases. Clinical Microbiology and Infection. 2017;23(9):647–652. doi: 10.1016/j.cmi.2017.04.004. PMID: 28457846.
Leave a comment